To join this case, fill out the form below
By clicking on the Submit button below, I acknowledge that I have read the Retainer Agreement and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
By clicking on the Submit button below, I acknowledge that I have read the Derivative Retention Letter and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
A signed Retainer Agreement will be sent to your email shortly.
Oops! Something went wrong while submitting the form.

NEOGEN Corporation Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of NEOGEN Corporation (“NEOGEN” or the “Company”) (NASDAQ:NEOG), in connection with the proposed merger of the Company with 3M Company(“3M”) (NYSE: MMM).  Under the terms of the agreement, 3M’s Food Safety business will be spun-off to 3M shareholders and simultaneously merged with a wholly owned subsidiary of NEOGEN.  At the completion of the transaction, NEOGEN will issue a number of shares to 3M shareholders such that 3M shareholders will receive approximately 50.1% of the combined company and existing NEOGEN shareholders will own approximately 49.9% of the combined company.  The transaction is valued at approximately $9.3 billion.

WeissLaw LLP is investigating whether (i) NEOGEN’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, and (ii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.